Gliquidone crystal, preparation method thereof and drug containing gliquidone crystal

A technology for gliquidone and crystals, applied in the field of medicinal chemistry, can solve the problems of low purity, poor stability and low safety of gliquizone, and achieve high product yield, high stability and good repeatability Effect

Inactive Publication Date: 2018-06-22
天津药物研究院药业有限责任公司
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The gliquidone obtained by the method for preparing gliquidone in the prior art is not high in pu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gliquidone crystal, preparation method thereof and drug containing gliquidone crystal
  • Gliquidone crystal, preparation method thereof and drug containing gliquidone crystal
  • Gliquidone crystal, preparation method thereof and drug containing gliquidone crystal

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The method for the preparation of gliquidone crystals adopted in the present embodiment is as follows:

[0033] Take 10 g of crude gliquidone and put it into a three-necked flask, add 20 g of acetonitrile, start stirring and heating. Heat it to reflux, and keep it under reflux, slowly add acetonitrile dropwise until it is completely dissolved (approximately 23g can be added to dissolve completely), after the dissolution is complete, continue to reflux for 2 hours, then filter while it is hot, and lower the temperature to 0-5°C with ice-salt water , and then heat and crystallize for 4 hours, filter, and dry the obtained solid in a blast oven at 50-60° C. for 6-8 hours to obtain 9.1 g of off-white solid with a yield of 91%. The purity of the gliquidone crystal form is 98.5%. , isoquinolines not exceeding 0.6%, figure 1 for its XRPD pattern, figure 2 For its XRPD data, it can be seen from the XRPD pattern and data results that the obtained gliquidone crystal form is A c...

Embodiment 2

[0035] The method for the preparation of gliquidone crystals adopted in the present embodiment is as follows:

[0036] Take 10 g of gliquidone and add it into a three-necked flask, add 20 g of acetonitrile, start stirring and heating. Heat it to reflux, and keep it under reflux, slowly add acetonitrile dropwise until it is completely dissolved (approximately 23g can be added to completely dissolve), after the dissolution is complete, continue to reflux for 2 hours, then filter while it is hot, and lower the temperature of ice-salt water to 0-5°C , and then heat and crystallize for 6 hours, filter, and dry the obtained solid in a blast oven at 50-60° C. for 6-8 hours. 9.0 g of off-white solid was obtained, the yield was 90%, the crystal form of gliquidone had a purity of 98.3%, and the isoquinoline was no more than 0.6%. figure 1 for its XRPD pattern, figure 2 For its XRPD data, it can be seen from the XRPD pattern and data results that the obtained gliquidone crystal form i...

Embodiment 3

[0038] The method for the preparation of gliquidone crystals adopted in the present embodiment is as follows:

[0039] Take 10 g of gliquidone and add it into a three-necked flask, add 20 g of acetonitrile, start stirring and heating. Heat it to reflux, and keep it under reflux, slowly add acetonitrile dropwise until it is completely dissolved (approximately 23g can be added to completely dissolve), after the dissolution is complete, continue to reflux for 2 hours, then filter while it is hot, and lower the temperature of ice-salt water to 0-5°C , and then heat and crystallize for 4 hours, filter, and dry the obtained solid in a blast oven at 60-70° C. for 6-8 hours. 9.1 g of off-white solid was obtained with a yield of 91%, the purity of the gliquidone crystal form was 98.2%, and the isoquinoline was no more than 0.6%. figure 1 for its XRPD pattern, figure 2 For its XRPD data, it can be seen from the XRPD pattern and data results that the obtained gliquidone crystal form i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a gliquidone crystal, a preparation method thereof and a drug containing the gliquidone crystal. The gliquidone crystal is a crystal form A, a crystal form B or a crystal form Cand is determined by using a powder X-ray diffraction method; according to an X-ray powder diffraction pattern represented by a diffraction angle of 2 theta plus or minus 0.20 degree; a crystal pattern A pattern shows diffraction peaks at 10.60 degrees, 14.00 degrees, 16.10 degrees, 18.98 degrees, 20.24 degrees and 21.46 degrees; a crystal pattern B pattern shows diffraction peaks at 10.60 degrees, 14.00 degrees, 15.30 degrees, 16.10 degrees, 16.54 degrees, 17.54 degrees, 18.53 degrees, 18.98 degrees, 19.33 degrees, 20.24 degrees, 21.46 degrees, 23.24 degrees and 25.35 degrees; and a crystalpattern C pattern shows diffraction peaks at 10.70 degrees, 15.24 degrees, 18.48 degrees, 23.24 degrees and 24.74 degrees. The preparation method comprises the following steps: dissolving a gliquidonecrude product in a solvent and then crystallizing to obtain the gliquidone crystal. The invention discloses a crystal structure of glitaquinone; the glitaquinone in a crystal state has higher solubleness and stronger storage stability than a glitaquinone compound in an amorphous state; and the gliquidone crystal prepared by the preparation method provided by the invention is high in purity, highin yield, simple in preparation process, high in repeatability and suitable for industrial production.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a gliquidone crystal, a preparation method thereof and medicine containing the crystal. Background technique [0002] Gliquidone, chemical name: 1-cyclohexyl-3-[[9-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxy -2-(1H)-isoquinolinyl)-ethyl]phenyl]sulfonyl]urea. Its structural formula is as follows: [0003] Gliquidone is the second-generation oral sulfonylurea hypoglycemic drug, which is a highly active pro-islet β-cell agent. It binds to specific receptors on the islet β-cell membrane and can induce the production of an appropriate amount of insulin to reduce blood sugar concentration. The highest plasma concentration is reached after 2-2.5 hours of oral administration of this product, and it will be completely absorbed soon. The plasma half-life is 1.5 hours, and the metabolism is complete. Its metabolites have no hypoglycemic effect, and most of the metaboli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D217/24A61K31/64A61P3/10
CPCC07B2200/13C07D217/24
Inventor 任晓峰赵欣许海涛王凯赵钊
Owner 天津药物研究院药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap